TD Asset Management
LOXO

TD Asset Management’s Loxo Oncology, Inc LOXO Stock Holding History

TD Asset Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-42,564
Closed -$5.96M – 1416
2018
Q4 		$5.96M Sell
42,564
-2,846
-6% -$432K 0.01% 610
2018
Q3 		$7.76M Buy
45,410
+3,100
+7% +$521K 0.01% 608
2018
Q2 		$7.34M Buy
42,310
+4,900
+13% +$736K 0.01% 592
2018
Q1 		$4.32M Buy
37,410
+8,100
+28% +$862K 0.01% 711
2017
Q4 		$2.47M Buy
29,310
+17,500
+148% +$1.46M ﹤0.01% 841
2017
Q3 		$1.09M Buy
11,810
+2,100
+22% +$163K ﹤0.01% 1008
2017
Q2 		$779K Buy
+9,710
New +$538K ﹤0.01% 1105

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

TD Asset Management's LOXO Position: Q1 2019 in Review

TD Asset Management sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 42,564 shares — an estimated $5.96M sold.

TD Asset Management first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $7.76M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • TD Asset Management reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • TD Asset Management sold 42,564 Loxo Oncology, Inc shares in Q1 2019, an estimated $5.96M.
  • TD Asset Management first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
  • TD Asset Management's Loxo Oncology, Inc position peaked at $7.76M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on TD Asset Management's 13F filing for Q1 2019, filed 8 May 2019.